Log In
BCIQ
Print this Print this
 

Helios ocular insert

  Manage Alerts
Collapse Summary General Information
Company ForSight Vision5 Inc.
DescriptionInsert that delivers bimatoprost, a prostaglandin analog, over a period of multiple months
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$95.0M

$95.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/11/2016

$95.0M

$95.0M

Undisclosed

Get a free BioCentury trial today